COMPASS Pathways plc
CMPS Nasdaq· Pharmaceutical Preparations
Last close · Oct 26, 2026
$11.05
KIRA · Stoqly’s AI analyst, in plain words
- COMPASS Pathways plc lost $288M in fiscal 2025.
- COMPASS Pathways plc has $100M more cash than debt.
Market cap
$1.5B
P/E
—
Revenue
—
Net income
−$288M
Free cash flow
—
Operating margin
—
COMPASS Pathways plc in 30 seconds · fiscal 2025
Does it make a profit?
−$288M
No. It lost money last year.
How healthy are the accounts?
1 / 7
Weak. It passes 1 of 7 health tests.
How is the share priced?
—
No P/E: it made no profit over the last four quarters.
What COMPASS Pathways plc does
No business description yet.
- Fiscal year ends
- December 31, 2025
- Latest annual report
- 10-K · Mar 24, 2026
- Legal name
- COMPASS Pathways plc
- CIK
- 0001816590
COMPASS Pathways plc · CMPS
Results and finances
The last 5 fiscal years. Amounts in USD.
| Fiscal year | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Sales and profit | |||||
| Net income | −$71.7M | −$91.5M | −$118M | −$155M | −$288M |
| Diluted EPS | −$1.79 | −$2.16 | −$2.32 | −$2.30 | −$3.08 |
| Cash | |||||
| Cash from operations | −$67.7M | −$105M | −$97.4M | −$119M | −$157M |
| Capital expenditure | $0.3M | $0.6M | $0.1M | $0.0M | — |
| Free cash flow | −$68.1M | −$106M | −$97.4M | −$119M | — |
| Share count change | 135.4% | 6.1% | 20.2% | 32.2% | 38.6% |
| Debt and strength | |||||
| Cash and short-term investments | $273M | $143M | $220M | $165M | $150M |
| Debt incl. finance leases | — | $0.0M | $28.8M | $35.7M | $49.2M |
| Shareholders' equity | $284M | $181M | $226M | $155M | −$52.8M |
| Current ratio | 19.5x | 12.3x | 13.3x | 5.9x | 0.8x |
| Interest coverage | — | — | −62.1x | −39.8x | −39.6x |
| Returns and quality | |||||
| Return on capital | — | −229.1% | −315.3% | −556.6% | — |
| Return on equity | −29.8% | −39.3% | −58.2% | −81.5% | −565.3% |
| Return on tangible equity | −25.2% | −50.5% | −52.5% | −100.3% | — |
| Piotroski F-score | — | — | 3 | 1 | 1 |
| Altman Z'' | 20.5 | 9.7 | 2.6 | −5.9 | −20.4 |
Insiders bought, 12 months
$0.0M
0 insiders
Insiders sold, 12 months
$0.0M
0 insiders
Of sales under plans
—
$0.0M
How to read these numbers
- Revenue:
- Total sales reported in the income statement.
- Operating margin:
- Operating income as a share of revenue.
- Net income:
- Profit after all expenses, interest and tax.
- Free cash flow:
- Cash from operations minus capital spending.
- Net debt / EBITDA:
- Years of EBITDA needed to pay off net debt. Below zero means more cash than debt.
- Return on capital:
- After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
COMPASS Pathways plc · CMPS
Charts and comparison
Ten years at a glance, and how it stacks up against similar companies.
Revenue
Net income
Margins, % of revenue
Cash vs debt (incl. leases)
Free cash flow
Dividends and buybacks
KIRA
At $11.05 a share, the company is worth $1.5B.
Source: SEC EDGAR XBRL filings (CIK 0001816590). Data updated October 24, 2026. For information only — not investment advice. Check the original filings before relying on any figure.